TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

Telix Pharmaceuticals announced that Managing Director and Group CEO Dr. Christian Behrenbruch will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The presentation will provide an overview of the company's pipeline assets and commercial portfolio, with a webcast available live and on-demand. Fourth quarter 2025 financials will be released on January 20, 2026.

Insights
TLX   positive

The company is presenting at a major healthcare industry conference, demonstrating investor engagement and confidence in its pipeline. The announcement of upcoming financial results and comprehensive pipeline overview suggests active development progress. References to FDA resubmissions for key candidates indicate advancement toward regulatory approvals.